Functional Nanoplatforms for Enhancement of Chemotherapeutic Index
- 作者: Yang J.1, Lee E.1, Ku M.1, Huh Y.1, Cheong J.1
-
隶属关系:
- ,
- 期: 卷 13, 编号 2 (2013)
- 页面: 212-221
- 栏目: Oncology
- URL: https://kld-journal.fedlab.ru/1871-5206/article/view/694877
- DOI: https://doi.org/10.2174/1871520611313020005
- ID: 694877
如何引用文章
全文:
详细
Recently, the advancement of nanotechnology has had a significant impact on clinical therapeutics. Advances in biocompatible drug carriers using organic/inorganic nanoparticles have enabled safer and more efficient delivery of anti-cancer agents. In particular, nanoparticles designed and fabricated by sophisticated processes can (as drug carriers) deliver precise doses of multiple anti-cancer agents to target cancer cells, improving therapeutic efficacy and minimizing side effects. In addition, a comprehensive understanding of cancer biology, chemo-resistance, cancer relapse, and metastasis is essential for successful development of combination therapy using nanoparticles. In this review, we discuss the species of functional nanoparticles for delivery of anti-cancer agents and their potential to improve chemotherapeutic indices via combination therapy. We also discuss novel therapeutic strategies using functional nanoparticles developed through multidisciplinary collaboration for combination chemotherapy.
作者简介
Jaemoon Yang
,
Email: info@benthamscience.net
Eugene Lee
,
Email: info@benthamscience.net
Minhee Ku
,
Email: info@benthamscience.net
Yong-Min Huh
,
Email: info@benthamscience.net
Jae-Ho Cheong
,
Email: info@benthamscience.net
补充文件
